Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion type Assertion NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_head.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion description "[These findings suggest that dual-targeting TAK1 and c-Myc might be a rational therapeutic strategy for treatment of certain types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion evidence source_evidence_literature NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion SIO_000772 23523871 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion wasDerivedFrom befree-20140225 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.
- NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_assertion wasGeneratedBy ECO_0000203 NP804478.RA-UzPNQCQ_PQmX1qLLInN-Z5Tp-Ghu96Jf-ciJHeVceQ130_provenance.